Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
ISIN: | DE000SLA5EB2 |
Bloomberg Ticker: | SOLFUPHA Index |
WKN: | SLA5EB |
Current Quotes
Last quote (20 Sep 2024): | 666.59 |
Day range: | 666.50 / 669.03 |
Change abs./rel.: | -1.89 / -0.28% |
Year range: | 533.32 / 697.32 |
Name | Number of shares |
---|---|
GENMAB A/S | 0.409759 |
NOVARTIS AG | 0.324411 |
SWEDISH ORPHAN BIOVITRUM AB | 0.632792 |
SANDOZ GROUP AG | 0.450667 |
GSK PLC | 1.754027 |
ASTRAZENECA PLC | 0.458509 |
NOVO NORDISK A/S | 0.287769 |
BAYER AG | 0.589147 |
GALDERMA GROUP AG | 0.202215 |
MERCK KGAA | 0.100444 |
RECORDATI SPA | 0.665518 |
SANOFI SA | 0.325401 |
UCB SA | 0.427833 |
ROCHE HOLDING AG | 0.290437 |
ARGENX SE | 0.210617 |